Why the study?
Does surgically created polytetrafluoroethylene (PTFE) bicuspid pulmonary valve implantation provide safe and effective outcomes in patients with pulmonary valve disease?
Population
126 patients with pulmonary insufficiency, pulmonary stenosis, or both, mean age 17.9 years, mean weight…
Design
Case_series
Follow-up
mean 3.34 years (range 0-8.3 years)
Authors
Loading...
Low mortality supports intermediate-term safety of PTFE bicuspid valves; leaves open optimal thickness and durability in larger cohorts.
Does surgically created polytetrafluoroethylene (PTFE) bicuspid pulmonary valve implantation provide safe and effective outcomes in patients with pulmonary valve disease?
Surgically created PTFE bicuspid pulmonary valves demonstrate acceptable intermediate-term safety and performance, with thinner 0.1-mm PTFE showing improved early echocardiographic outcomes compared to 0.6-mm PTFE.
Quintessenza et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: